Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,037 | 17,703 | 19,050 | 33,617 | 27,806 |
| Receivables | 113,540 | 106,741 | 107,770 | 110,168 | 99,941 |
| Inventories | 48,224 | 45,443 | 44,056 | 38,946 | 39,117 |
| Other current assets | 4,780 | 5,109 | 5,347 | 6,187 | 5,846 |
| TOTAL | $202,192 | $189,055 | $187,245 | $201,149 | $185,817 |
| Non-Current Assets | |||||
| PPE Net | 109,926 | 110,952 | 112,736 | 112,398 | 113,491 |
| Intangibles | 107,424 | 107,584 | 107,691 | 107,762 | 107,868 |
| Other Non-Current Assets | 165,376 | 173,262 | 178,607 | 177,116 | 177,270 |
| TOTAL | $382,726 | $391,798 | $399,034 | $397,276 | $398,629 |
| Total Assets | $584,918 | $580,853 | $586,279 | $598,425 | $584,446 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 34,405 | 29,726 | 35,015 | 30,383 | 25,500 |
| Accrued Expenses | 26,465 | 20,833 | 21,753 | 20,477 | 23,063 |
| Other current liabilities | 8,042 | 7,683 | 6,660 | 6,812 | 6,829 |
| TOTAL | $99,762 | $90,782 | $92,953 | $90,854 | $85,533 |
| Non-Current Liabilities | |||||
| Long Term Debt | 189,807 | 188,636 | 188,463 | 208,305 | 208,166 |
| Deferred Revenues | 7,602 | 7,765 | 6,867 | 6,410 | 5,864 |
| Other Non-Current Liabilities | 105,644 | 116,000 | 119,877 | 124,088 | 124,119 |
| TOTAL | $318,770 | $329,070 | $332,312 | $353,227 | $352,867 |
| Total Liabilities | $418,532 | $419,852 | $425,265 | $444,081 | $438,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,308 | 46,277 | 46,290 | 46,331 | 46,306 |
| Common Shares | 1,188 | 1,188 | 1,188 | 1,188 | 1,188 |
| Retained earnings | 65,998 | 68,349 | 66,123 | 65,712 | 58,115 |
| Other shareholders' equity | -1,888 | -5,656 | -5,324 | -5,811 | -3,615 |
| TOTAL | $166,386 | $161,001 | $161,014 | $154,344 | $146,046 |
| Total Liabilities And Equity | $584,918 | $580,853 | $586,279 | $598,425 | $584,446 |